Anda Filings
Feb 09, 2012 at 14:16 | Source: CNBC-TV18
Aug 09, 2011 at 20:27 | Source: PTI
Jun 23, 2011 at 12:20 | Source: Moneycontrol.com
Apr 07, 2011 at 17:14 | Source: CNBC-TV18
Feb 09, 2011 at 16:15 | Source: CNBC-TV18
Jul 22, 2010 at 18:43 | Source: CNBC-TV18
News across the web »
May 16, 2012 at 00:26 | Source: The Hindu BusinessLine
Apr 28, 2012 at 21:42 | Source: The Hindu BusinessLine
Apr 27, 2012 at 02:35 | Source: The Hindu BusinessLine
Apr 23, 2012 at 23:27 | Source: The Hindu BusinessLine
Apr 09, 2012 at 11:07 | Source: India Infoline
Interact & exchange stock tips & market info »
Related News »
This letter also stated that ANDA No. 09--1073 contained Paragraph IV certifications ... on file with the Securities and Exchange Commission (the "SEC"). Our SEC filings may be accessed electronically by means of the SEC's home page on the ...
May 24, 2012 at 09:24 | Source: Marketwatch
Watson's ANDA product is a generic version of Warner Chilcott Company ... and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's ...
May 28, 2012 at 06:13 | Source: Yahoo Finance
The cumulative ANDA (Abbreviated New Drug Application) filings count in the US stands at 43. This includes 8 Para IV FTF (First-To-File) filings. The break-up of the total ANDA filings is 13 in the Cephalosporins space and 30 in the NPNC (Non-penicillin ...
May 14, 2012 at 14:29 | Source: 4-traders (press release)
Watson's ANDA product is a generic version of Shire Development ... and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Quarterly ...
May 28, 2012 at 02:24 | Source: Yahoo Finance
FDA Approvals and Filings During the quarter ... Taro also received one Abbreviated New Drug Application ("ANDA") approval in May 2012 (Escitalopram Oxalate Oral Solution, 5mg (base)/5mL). The total number of products awaiting approval at ...
May 24, 2012 at 20:22 | Source: Marketwatch
Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business ... and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission ...
May 23, 2012 at 23:58 | Source: Seekingalpha.com
Perrigo was the first applicant to submit a substantially complete ANDA with a paragraph IV certification and ... as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements ...
May 21, 2012 at 23:54 | Source: 4-traders (press release)
We have an ANDA under review for a generic Copaxone and we also have ... USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY'S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY'S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS.
May 19, 2012 at 00:26 | Source: Seekingalpha.com
During the year, Wockhardt USA received nine ANDA product approvals and launched six products. Overall it currently markets more than 70 products. There were 150 global patent filings by the company, out of which 44 patents were granted, it added.
May 22, 2012 at 11:35 | Source: MSN India
During the year, Wockhardt USA received nine ANDA product approvals and launched six products. Overall it currently markets more than 70 products. There were 150 global patent filings by the company, out of which 44 patents were granted, it added.
May 22, 2012 at 11:35 | Source: Business Standard